Provided by Tiger Trade Technology Pte. Ltd.

Alvotech

5.10
+0.08001.59%
Post-market: 5.200.1045+2.05%16:23 EDT
Volume:3.86M
Turnover:20.59M
Market Cap:1.82B
PE:-8.39
High:5.53
Open:5.40
Low:5.10
Close:5.02
52wk High:9.25
52wk Low:2.94
Shares:357.00M
Float Shares:141.00M
Volume Ratio:6.29
T/O Rate:2.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6081
EPS(LYR):0.0964
ROE:--
ROA:2.19%
PB:-9.51
PE(LYR):52.93

Loading ...

Alvotech Shares Rise After Double Upgrade From Barclays

MT Newswires Live
·
2 hours ago

Alvotech Price Target Raised to $8.00/Share from $4.00 by Barclays

Dow Jones
·
Yesterday

Alvotech : Barclays Raises to Overweight from Underweight

THOMSON REUTERS
·
Yesterday

Alvotech upgraded to Overweight from Underweight at Barclays

TIPRANKS
·
Yesterday

Positive Report for Alvotech (ALVO) from Barclays

TIPRANKS
·
Yesterday

Regeneron Pharmaceuticals More Likely to Retain Eylea HD Patent, RBC Says

MT Newswires Live
·
Sep 10

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
Sep 01

Alvotech Stock Gains After FDA Accepts for Review Crohn's Treatment AVT80

Dow Jones
·
Sep 01

Alvotech Says FDA Accepts AVT80 Biosimilar Application for Review

Reuters
·
Aug 31

Alvotech Announces FDA Acceptance for Review of Biologics License Application for Avt80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations

THOMSON REUTERS
·
Aug 31

Alvotech Executives to Speak at Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Alvotech to present at upcoming investor conferences in September

GlobeNewswire
·
Aug 27

Alvotech's Q4 Approval, Launch Timelines Remain Intact, UBS Says

MT Newswires Live
·
Aug 25

Alvotech Sa : Bofa Global Research Initiates Coverage with Buy Rating; Price Objective $7

THOMSON REUTERS
·
Aug 24

BofA Securities Initiates Alvotech at Buy With $7 Price Target

MT Newswires Live
·
Aug 24

Lotus Pharma Unit to License Two Alvotech Biosimilars in $150 Million Deal

MT Newswires Live
·
Aug 24

Alvotech Strikes $150 Million Biosimilar Deal With Lotus for U.S. and Key Asian Markets

TIPRANKS
·
Aug 21

Alvotech Signs Licensing, Commercialization Deal with Lotus Pharma for Imfinzi, Hemlibra Biosimilars in US, Asia

Reuters
·
Aug 21

Alvotech - Announces Strategic Licensing and Commercialization Agreement with Lotus Pharmaceutical

THOMSON REUTERS
·
Aug 21

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for Proposed Biosimilars to Durvalumab and Emicizumab in the U.S. and Selected Asian Markets

THOMSON REUTERS
·
Aug 21